| 2924.29.76 | 20 | Acetoacet-2,5-dimethoxy-4- chloroanilide | kg | | | |
| 2926.90.05 | 00 | 2-Amino-4-chlorobenzonitrile (5-Chloro-2- cyanoaniline); 2-Amino-5-chlorobenzonitrile; 4-Amino-2-chlorobenzonitrile; (Cyanoethyl)(hydroxyethyl)-m-toluidine; p-Cyanophenyl acetate; Phthalonitrile; and Tetrachloro-3-cyanobenzoic acid, methyl ester | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 41% |
| 2930.20.20 | 10 | Products used principally for rubber processing | kg | | | |
| 2930.20.90 | 20 | Products used principally for rubber processing | kg | | | |
| 2930.90.91 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.69.60 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.99.08 | 00 | Acetoacetyl-5-aminobenzimidazolone; 3-(2H-Benzotriazol-2-yl)-5-(tert-butyl)-4- hydroxybenzene propanoic acid, C7-C9 branched or linear alkyl esters; 2-(2H-Benzotriazol-2-yl)-6-dodecyl-4- methyl phenol, in liquid form, branched and linear; and 1,3,3-Trimethyl-2-methyleneindoline | kg | Free | | 15.4￠/kg + 52% |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2934.10.70 | 00 | 4,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloride | kg | Free | | 30.5% |
| 2934.99.03 | 00 | 2-Acetylbenzo(b)thiophene; 3-Methylene-7-(2-phenoxyacetamido)- cephan-4-carboxylic acid, p-nitrobenzyl ester, 1-oxide; and Naphth[1,2-d]-[1,2,3]-oxadiazole-5-sulfonic acid and its sodium salt | kg | Free | | 15.4￠/kg + 52% |
| 2935.00.29 | 00 | Acetylsulfaguanidine | kg | Free | | 15.4￠/kg + 96% |
| 2935.00.32 | 00 | Acetylsulfisoxazole; Sulfacetamide, sodium; and Sulfamethazine, sodium | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 96% |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2936.29.15 | 10 | Pharmaceutical grade | kg | | | |
| 2936.90.01 | | Other, including proviatmins and natural concentrates | | Free | | 25% |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2938 | | XII. GLYCOSIDES AND VEGETABLE ALKALOIDS, NATURAL OR REPRODUCED BY SYNTHESIS, AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES | | | | |
| 2938 | | Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: | | | | |
| 2939 | | Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: | | | | |
| 2939.11.00 | 00 | Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof | kg | Free | | 15.4￠/kg + 50% |
| 2939.91.00 | 00 | Cocaine, ecgonine, levometamfetamine, metamfetamine (INN), metamfetamine racemate; salts, esters and other derivatives thereof | kg | Free | | 25% |
| 2940..00 | | Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 2937, 2938 or 2939: | | | | |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
